Alexandria New Medical Center (EGX:AMES)

EGX:AMES Financials Overview

Financials in millions EGP. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	480.15	467.9	353.16	277.73	261.03	275.16
Revenue Growth	24.22%	32.49%	27.16%	6.40%	-5.13%	22.08%
Gross Profit Gross Profit Growth	148.73	146.62	101.54	63.19	74.16	100.99
Operating Income Operating Income Growth	68.93	68.1	32.73	9.54	10.57	47.17
Net Income Net Income Growth	56.36	55.04	29.82	5.93	-0.7	26.58
Earnings Per Share EPS Growth	0.45	0.44	0.24	0.05	-0.01	0.21
EPS Growth	57.85%	84.61%	402.63%	-	-	27.47%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Specialized Units Specialized Units Growth	99.26	94.02	66.93	65.67	50.81
Outpatient and Emergency Clinics Outpatient and Emergency Clinics Growth	68.87	67.15	50.68	38.71	34.46
Accommodation and Medical Supervision Accommodation and Medical Supervision Growth	89.14	87.62	67.43	41.05	44.57
Lab and X-Ray Lab and X-Ray Growth	59.59	56.27	37.51	32.42	31.04
Medicines and Medical Supplies Medicines and Medical Supplies Growth	143.38	143.17	112.88	85.02	87.8
Blood Bank Blood Bank Growth	18.16	18.06	16.28	13.61	10.27
Off-Site Services Off-Site Services Growth	1.74	1.61	1.44	1.26	2.08
Total Total Growth	480.15	467.9	353.16	277.73	261.03

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	40.64	41.1	34.81	41.52	53.58	66.13
Total Debt Total Debt Growth	-	15.52	35.18	-	6.48	18.21
Net Cash (Debt) Net Cash Growth	40.64	25.58	-0.37	41.52	47.1	47.92
Net Cash Growth	267.09%	-	-	-11.85%	-1.71%	621.72%
Net Cash Per Share Net Cash Per Share Growth	0.33	0.21	-0.00	0.33	0.38	0.38

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	9.62	21.09	26.51	-0.9	-0.42	54.46
Capital Expenditures CapEx Growth	-15.77	-20.51	-40.64	-14.07	-6.98	-13.78
Free Cash Flow Free Cash Flow Growth	-6.15	0.58	-14.13	-14.97	-7.4	40.68
Free Cash Flow Growth	-	-	-	-	-	-4.02%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	30.98%	31.34%	28.75%	22.75%	28.41%	36.70%
Operating Margin	14.36%	14.56%	9.27%	3.44%	4.05%	17.14%
Pretax Margin	15.55%	15.69%	11.90%	5.06%	5.65%	16.50%
Profit Margin	11.74%	11.76%	8.44%	2.14%	-0.27%	9.66%
FCF Margin	-1.28%	0.12%	-4.00%	-5.39%	-2.84%	14.78%

Dividends

Chart

Fiscal Year	FY 2021
Period Ending	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	0.100
Dividend Per Share Growth	-
Dividend Yield	2.87%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 5, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	246.43	124.73	77.17	154.36	-	31.95
P/FCF Ratio	-	11917.45	-	-	-	20.88
PS Ratio	28.92	14.67	6.52	3.30	4.39	3.09

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 5, 2026

Data Sources Report a data error